Business Segments · Other adjustments
Oncology & Multispecialty — Other adjustments
McKesson Oncology & Multispecialty — Other adjustments increased by 52.9% to -$6.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 52.9%, from -$12.75M to -$6.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryOther
SignalLower is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ3 2026Feb 4, 2026
Rolls up toPurchase Price Adjustments
How to read this metric
Frequent or large adjustments may indicate poor forecasting or volatile operational environments.
Detailed definition
Miscellaneous adjustments to segment financial results that do not fall into standard categories like restructuring or i...
Peer comparison
Often found in segment reconciliation tables as 'Other' or 'Miscellaneous' adjustments.
Metric ID:
mck_segment_oncology_multispecialty_other_adjustmentsHistorical Data
5 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q3 '26 | |
|---|---|---|---|---|---|
| Value | -$12.75M | -$12.75M | -$12.75M | -$12.75M | -$6.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +52.9% |
| YoY Change | — | — | — | — | +52.9% |
Range-$12.75M – -$6.00M
CAGR-52.9%
Avg YoY Growth+52.9%
Median YoY Growth+52.9%
Current Streak4+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — other adjustments?
- McKesson (MCK) reported oncology & multispecialty — other adjustments of -$6.00M in Q4 2025.
- How has McKesson's oncology & multispecialty — other adjustments changed year-over-year?
- McKesson's oncology & multispecialty — other adjustments increased by 52.9% year-over-year, from -$12.75M to -$6.00M.
- What does oncology & multispecialty — other adjustments mean?
- Non-standard, one-time adjustments to segment earnings.